Advertisement

Qualigen Therapeutics, Inc. QLGN

Set alert

Price alert · QLGN

All alert types
3.21 0.00 0.00%

At close · Nov 18

2.86 Day range 3.34
3.34 52-week range 30.50
YTD
-23.75%
1 year
-11.81%
Open
2.98
Prev close
3.21
Mkt cap
2.98M
Vol
368.77K
Avg vol
92.24K
EPS
3,635.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.86
High
3.34
Forward P/E
-4.04
Beta
0.14
Short ratio
0.11
Inst. own
1.77%
Dividend
0.00
Ex-div date
Earnings
May 7, 2024
50-d avg
5.21
200-d avg
10.89
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for QLGN has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $18.54KExpenses → Selling, General & Admin: $2.97MExpenses → Research & Development: $1.51MExpenses → Income Tax: $5.44KGross Profit → Expenses: $330.86KRevenue → Gross Profit: $330.86KRevenue → Cost of Revenue: $1.10MNet Loss → Expenses: $4.12MOther Income$18.54KGross Profit$330.86KNet Loss$4.12MCost of Revenue$1.10MExpenses$4.47MSelling, General & Admin$2.97MResearch & Development$1.51MIncome Tax$5.44KRevenue$1.43M

Period ending Jun 30, 2025 · select a line to chart its history

Income statement

QLGN quarterly income statement
1.68M
17.82K
1.39M
-1.68M
106.05K
-1.69M
-1.69M
-1.69M
-1.69M
1.59K
-1.00
-1.00
-1.00
-1.58M
-1.58M
1.59K
1.68M
1.68M

Balance sheet

QLGN quarterly balance sheet
331.60K
331.60K
3.31M
3.31M
3.96M
3.96M
3.62M
3.62M
5.61M
5.61M
-127.39M
-1.65M
-1.65M
2.00K
3.62M
1.40M

Cash flow

QLGN quarterly cash flow
2.61M
301.39K
2.61M
-1.21M
-1.21M
-1.10M
Advertisement